Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Orphanet Journal of Rare Diseases|June 4, 2021
Epidemiology and burden of progressive familial intrahepatic cholestasis: a systematic reviewTracey Jones-Hughes, Jo Campbell, Louise Crathorne
Health Technology Assessment (Winchester, England)|January 29, 2015
What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluationsLinda Long, Simon Briscoe, Chris Cooper, et al.
BMJ Open|June 2, 2012
The best of the UK? A report on the value and future of UK databases in the health and social care fields: a systematic map protocolChris Cooper, Alison O'Mara-Eves, Morwenna Rogers, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 30, 2013
Cost-effectiveness of cetuximab, cetuximab plus irinotecan, and panitumumab for third and further lines of treatment for KRAS wild-type patients with metastatic colorectal cancerMartin Hoyle, Jaime Peters, Louise Crathorne, et al.
Pharmacoeconomics|March 3, 2018
Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in EnglandIrina A Tikhonova, Nicola Huxley, Tristan Snowsill, et al.
Journal of Clinical Epidemiology|May 3, 2017
Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological reviewAdam J Streeter, Nan Xuan Lin, Louise Crathorne, et al.
The International Journal of Health Planning and Management|November 3, 2023
Evaluation of an acute trust Domestic Abuse Coordinator role: Impact findings and a budget impact modelG J Melendez-Torres, Louise Crathorne, Eleanor Hepworth, et al.
BMC Anesthesiology|October 8, 2016
First do no harm: pain relief for the peripheral venous cannulation of adults, a systematic review and network meta-analysisMary Bond, Louise Crathorne, Jaime Peters, et al.
Health Technology Assessment (Winchester, England)|July 7, 2017
The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluationNicola Huxley, Louise Crathorne, Jo Varley-Campbell, et al.
Pharmacoeconomics|September 3, 2020
Voretigene Neparvovec for Treating Inherited Retinal Dystrophies Caused by RPE65 Gene Mutations: An Evidence Review Group Perspective of a NICE Highly Specialised Technology AppraisalCaroline Farmer, Ash Bullement, David Packman, et al.
Pageof 3